# Reply: Sodium-Glucose Cotransporter 2 Inhibitor Use and Outcomes in Transthyretin Amyloid Cardiomyopathy

**Authors:** Vikash Jaiswal, Muhammad Hanif, Yusra Mashkoor, Tanisha Prasad, Gregg C. Fonarow

PMC · DOI: 10.1016/j.jacadv.2025.101696 · JACC: Advances · 2025-04-25

## Full-text entities

- **Diseases:** Transthyretin Amyloid Cardiomyopathy (MESH:C567782)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12103093/full.md

## References

3 references — full list in the complete paper: https://tomesphere.com/paper/PMC12103093/full.md

---
Source: https://tomesphere.com/paper/PMC12103093